1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow betrixaban: new trials by email Literature Review of betrixaban trials Research Report on betrixaban
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) Betrixaban, Enoxaparin - Venous Thromboembolism (VTE) | Phase 3 | Completed | Portola Pharmaceuticals | 7513 | 2012-03-01 | 2023-08-07 |
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Croatia (1) · Czechia (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1) · Georgia (1)
PMID 24576517, PMID 27232649, PMID 27881569, PMID 28617144, PMID 28625365, PMID 28698258, PMID 28762617, PMID 28840662, PMID 28905172, PMID 29188425, PMID 29212126, PMID 30252149, PMID 30419597, PMID 30778649, PMID 31215264, PMID 31249989, PMID 32657973, PMID 36566304